HNSPF
Price
$4.40
Change
-$0.28 (-5.98%)
Updated
Aug 5 closing price
Capitalization
28.25B
TSMRF
Price
$23.74
Change
-$4.41 (-15.67%)
Updated
Jun 27 closing price
Capitalization
1.8B
Interact to see
Advertisement

HNSPF vs TSMRF

Header iconHNSPF vs TSMRF Comparison
Open Charts HNSPF vs TSMRFBanner chart's image
Hansoh Pharmaceutical Group
Price$4.40
Change-$0.28 (-5.98%)
Volume$600
Capitalization28.25B
Tsumura & Co
Price$23.74
Change-$4.41 (-15.67%)
Volume$100
Capitalization1.8B
HNSPF vs TSMRF Comparison Chart in %
Loading...
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HNSPF vs. TSMRF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSPF is a Hold and TSMRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (HNSPF: $4.40 vs. TSMRF: $23.74)
Brand notoriety: HNSPF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HNSPF: 58% vs. TSMRF: 100%
Market capitalization -- HNSPF: $28.25B vs. TSMRF: $1.8B
HNSPF [@Pharmaceuticals: Generic] is valued at $28.25B. TSMRF’s [@Pharmaceuticals: Generic] market capitalization is $1.8B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSPF’s FA Score shows that 2 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • HNSPF’s FA Score: 2 green, 3 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, HNSPF is a better buy in the long-term than TSMRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HNSPF’s TA Score shows that 2 TA indicator(s) are bullish while TSMRF’s TA Score has 2 bullish TA indicator(s).

  • HNSPF’s TA Score: 2 bullish, 3 bearish.
  • TSMRF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, both HNSPF and TSMRF are a good buy in the short-term.

Price Growth

HNSPF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while TSMRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($28.3B) has a higher market cap than TSMRF($1.8B). HNSPF has higher P/E ratio than TSMRF: HNSPF (43.25) vs TSMRF (8.18). HNSPF YTD gains are higher at: 106.263 vs. TSMRF (-15.672).
HNSPFTSMRFHNSPF / TSMRF
Capitalization28.3B1.8B1,571%
EBITDAN/A47.8B-
Gain YTD106.263-15.672-678%
P/E Ratio43.258.18529%
RevenueN/A165B-
Total CashN/A82.4B-
Total DebtN/A71.4B-
FUNDAMENTALS RATINGS
TSMRF: Fundamental Ratings
TSMRF
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
31
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HNSPFTSMRF
RSI
ODDS (%)
Bearish Trend 3 days ago
25%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
57%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 5 days ago
10%
MACD
ODDS (%)
Bearish Trend 3 days ago
29%
Bullish Trend 3 days ago
17%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
26%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
24%
Bullish Trend 3 days ago
12%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
12%
View a ticker or compare two or three
Interact to see
Advertisement
HNSPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TERN7.050.28
+4.14%
Terns Pharmaceuticals
UNB27.300.30
+1.11%
Union Bankshares
ON51.09-0.53
-1.03%
ON Semiconductor Corp
BUR13.40-0.18
-1.33%
Burford Capital Limited
MSN0.47-0.03
-5.52%
Emerson Radio Corp

HNSPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSPF has been loosely correlated with SBFM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSPF jumps, then SBFM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
SBFM - HNSPF
46%
Loosely correlated
-1.33%
GEDSF - HNSPF
33%
Loosely correlated
N/A
TSMRF - HNSPF
29%
Poorly correlated
N/A
ACB - HNSPF
27%
Poorly correlated
-5.75%
OGI - HNSPF
23%
Poorly correlated
-8.33%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and ACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
ACB - TSMRF
30%
Poorly correlated
-5.75%
HNSPF - TSMRF
29%
Poorly correlated
N/A
GEDSF - TSMRF
22%
Poorly correlated
N/A
TLRY - TSMRF
22%
Poorly correlated
-12.71%
CGC - TSMRF
21%
Poorly correlated
-12.75%
More